Why did Mondelēz's Q4 2024 margins decline so sharply despite reported EPS rising 85.7%?

Reported Q4 diluted EPS of $1.30 was inflated by favorable mark-to-market derivative gains ($700 million at the operating income level), a $332 million gain on the JDE Peet's sale, and acquisition-related income. On an adjusted basis, EPS was $0.65, down 15.9% at constant currency. Adjusted Gross Profit margin fell 650 basis points to 31.5%, primarily due to higher raw material and transportation costs, especially cocoa, which were only partially offset by pricing and productivity gains.

What is driving the 2025 Adjusted EPS guidance decline of roughly 10%?

Management attributes the expected decline to unprecedented cocoa cost inflation. The company is relying on its chocolate business playbook and agile cost actions to mitigate the impact, but the guidance implies that pricing and productivity will not fully offset the input cost pressure in 2025. Currency translation is an additional headwind, estimated at -$0.12 to Adjusted EPS.

How strong is Mondelēz's cash generation and balance sheet?

Operating cash flow was $4.9 billion in 2024, and Free Cash Flow of $3.5 billion covered $4.7 billion in shareholder returns only when combined with the proceeds from divestitures, such as the JDE Peet's sale. Total debt fell to $17.7 billion and net debt to $16.4 billion, a $1.2 billion reduction year over year. Management guides to Free Cash Flow of $3 billion or more in 2025, which is lower than 2024 levels and leaves less room for shareholder returns without further deleveraging or asset sales.

Does the 2025 outlook account for potential U.S. tariffs?

No. The outlook explicitly excludes the impact of any U.S. import tariffs and potential retaliatory measures by other countries, which management says are uncertain and rapidly evolving. Investors should treat tariffs as an additional downside risk to the guidance, particularly given Mondelēz's global supply chain and exposure to commodity and trade-sensitive inputs.

Were there any unusual or non-recurring items affecting 2024 reported results?

Yes. Reported 2024 results included a $665 million (pre-tax) JDE Peet's impairment in Q1 and a $332 million gain on the Q4 sale of the remaining JDE Peet's stake, along with $544 million of net unrealized derivative gains, $153 million of intangible asset impairments, and $393 million of income from Clif Bar contingent consideration adjustments. Because these items vary widely from period to period, investors should evaluate underlying performance using Adjusted metrics and reconcile them against GAAP results in the press release schedules.

MDLZ 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed February 4, 2025. Cited figures are marked; the original filing is the authoritative source.

Mondelēz International (MDLZ) reported Q4 and full-year 2024 results on February 4, 2025, showing solid top-line and cash performance overshadowed by a sharp fourth-quarter margin compression.

Full-year net revenues rose 1.2% to $36.4 billion^a, with Organic Net Revenue growth of 4.3% driven by higher net pricing, partly offset by a 1.0 point volume/mix decline. Reported diluted EPS fell 5.5% to $3.42, but Adjusted EPS rose 13.0% on a constant currency basis to $3.36, aided by operating gains, fewer shares outstanding, and lower taxes. Free cash flow was $3.5 billion, and the company returned $4.7 billion to shareholders through dividends and buybacks.

Net debt declined by $1.2 billion to $16.4 billion^b, and the company fully exited its JDE Peet's stake in November 2024. The key concern for investors is the outlook. In Q4, Adjusted Gross Profit margin fell 650 basis points to 31.5% and Adjusted Operating Income fell 28.2% at constant currency, driven by sharply higher raw material costs, principally cocoa.

Management guided 2025 Adjusted EPS to decline roughly 10% on a constant currency basis due to what it calls unprecedented cocoa cost inflation, while expecting Organic Net Revenue growth of about 5% and Free Cash Flow of $3 billion^c or more. Currency translation is expected to reduce 2025 net revenue growth by about 2.5% and Adjusted EPS by $0.12. The outlook excludes any potential U.S. tariffs and retaliation, which management describes as uncertain and rapidly evolving.

Reported results were also flattered by non-recurring and non-cash items, including $544 million^d of net unrealized derivative gains in 2024, a $332 million gain on the JDE Peet's sale in Q4, and $393 million of Clif Bar integration and contingent consideration income. These were offset by a $665 million JDE Peet's impairment in Q1 and $153 million of intangible impairments. Investors should therefore focus on Adjusted metrics and the 2025 cocoa-driven earnings reset rather than the headline GAAP EPS decline or Q4 reported EPS increase of 85.7%.

02—Key points

Key Highlights

FY2024 net revenues rose 1.2% to $36.4 billion; Organic Net Revenue grew 4.3%, driven by net pricing, with volume/mix down 1.0%.
Diluted EPS fell 5.5% to $3.42 on GAAP basis, but Adjusted EPS rose 13.0% at constant currency to $3.36, helped by fewer shares, lower taxes and operating gains.
Q4 Adjusted Gross Profit margin declined 650 bps to 31.5% and Adjusted Operating Income fell 28.2% at constant currency, reflecting higher raw material and transportation costs, mainly cocoa.
Free Cash Flow was $3.5 billion (operating cash flow of $4.9 billion less $1.4 billion capex); capital returned to shareholders totaled $4.7 billion.
2025 guidance: Organic Net Revenue growth of ~5%, Adjusted EPS down ~10% at constant currency due to cocoa inflation, and Free Cash Flow of $3+ billion; currency is a ~2.5% headwind to revenue and -$0.12 to Adjusted EPS.
Balance sheet improved with net debt down $1.2 billion to $16.4 billion, and the company fully exited its JDE Peet's stake in November 2024 for $2.3 billion in proceeds.
GAAP results were boosted by non-recurring items, including $544 million of net unrealized derivative gains and $393 million of Clif Bar integration/contingent consideration income, partly offset by a $665 million JDE Peet's impairment.

03—Questions

Frequently Asked Questions

Why did Mondelēz's Q4 2024 margins decline so sharply despite reported EPS rising 85.7%?
Reported Q4 diluted EPS of $1.30 was inflated by favorable mark-to-market derivative gains ($700 million at the operating income level), a $332 million gain on the JDE Peet's sale, and acquisition-related income. On an adjusted basis, EPS was $0.65, down 15.9% at constant currency. Adjusted Gross Profit margin fell 650 basis points to 31.5%, primarily due to higher raw material and transportation costs, especially cocoa, which were only partially offset by pricing and productivity gains.
What is driving the 2025 Adjusted EPS guidance decline of roughly 10%?
Management attributes the expected decline to unprecedented cocoa cost inflation. The company is relying on its chocolate business playbook and agile cost actions to mitigate the impact, but the guidance implies that pricing and productivity will not fully offset the input cost pressure in 2025. Currency translation is an additional headwind, estimated at -$0.12 to Adjusted EPS.
How strong is Mondelēz's cash generation and balance sheet?
Operating cash flow was $4.9 billion in 2024, and Free Cash Flow of $3.5 billion covered $4.7 billion in shareholder returns only when combined with the proceeds from divestitures, such as the JDE Peet's sale. Total debt fell to $17.7 billion and net debt to $16.4 billion, a $1.2 billion reduction year over year. Management guides to Free Cash Flow of $3 billion or more in 2025, which is lower than 2024 levels and leaves less room for shareholder returns without further deleveraging or asset sales.
Does the 2025 outlook account for potential U.S. tariffs?
No. The outlook explicitly excludes the impact of any U.S. import tariffs and potential retaliatory measures by other countries, which management says are uncertain and rapidly evolving. Investors should treat tariffs as an additional downside risk to the guidance, particularly given Mondelēz's global supply chain and exposure to commodity and trade-sensitive inputs.
Were there any unusual or non-recurring items affecting 2024 reported results?
Yes. Reported 2024 results included a $665 million (pre-tax) JDE Peet's impairment in Q1 and a $332 million gain on the Q4 sale of the remaining JDE Peet's stake, along with $544 million of net unrealized derivative gains, $153 million of intangible asset impairments, and $393 million of income from Clif Bar contingent consideration adjustments. Because these items vary widely from period to period, investors should evaluate underlying performance using Adjusted metrics and reconcile them against GAAP results in the press release schedules.

04—Continue

← View all 8-K filings